Immunotherapy in advanced anal cancer: Is the beginning of a new era?
D Ciardiello, LP Guerrera, BA Maiorano… - Cancer Treatment …, 2022 - Elsevier
For decades metastatic squamous cell carcinoma of the anus (SCCA) has been considered
a rare disease with very limited treatment options and a dismal prognosis. Prior to 2017, no …
a rare disease with very limited treatment options and a dismal prognosis. Prior to 2017, no …
[HTML][HTML] Advances in the diagnosis and therapeutic management of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
K Kaliszewski, M Ludwig, M Greniuk, A Mikuła… - Cancers, 2022 - mdpi.com
Simple Summary Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a
group of tumors with different clinical manifestations, various localizations in the human …
group of tumors with different clinical manifestations, various localizations in the human …
[HTML][HTML] Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023)
YN Li, B Xie, Y Zhang, MH He, Y Xing… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Gastric cancer (GC) is the sixth most common cancer and third leading
cause of cancer-related deaths worldwide. Current treatments mainly rely on surgery-and …
cause of cancer-related deaths worldwide. Current treatments mainly rely on surgery-and …
[HTML][HTML] Store-Operated Ca2+ Entry Is Up-Regulated in Tumour-Infiltrating Lymphocytes from Metastatic Colorectal Cancer Patients
Simple Summary Store-operated Ca2+ entry (SOCE) has long been known to regulate the
differentiation and effector functions of T cells as well as to be instrumental to the ability of …
differentiation and effector functions of T cells as well as to be instrumental to the ability of …
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
C Panebianco, D Ciardiello, A Villani… - Seminars in Cancer …, 2022 - Elsevier
Microbiota consists of a dynamic organization of bacteria, viruses, archaea, and fungal
species involved in a number of vital functions spanning from the digestion of carbohydrates …
species involved in a number of vital functions spanning from the digestion of carbohydrates …
[HTML][HTML] Advances in adoptive cellular therapy for colorectal cancer: a narrative review
X Yi, W Hu - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
Methods We searched PubMed for articles related to ACT for CRC published as of August
31, 2022, and retrieved relevant clinical trial information on the National Institutes of Health …
31, 2022, and retrieved relevant clinical trial information on the National Institutes of Health …
[HTML][HTML] Lipid nanoparticles for mRNA delivery to enhance cancer immunotherapy
Messenger RNA (mRNA) is being developed by researchers as a novel drug for the
treatment or prevention of many diseases. However, to enable mRNA to fully exploit its …
treatment or prevention of many diseases. However, to enable mRNA to fully exploit its …
[HTML][HTML] The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
D Li, D Cao, Y Sun, Y Cui, Y Zhang, J Jiang… - Frontiers in …, 2024 - frontiersin.org
Cancer, a disease that modern medicine has not fully understood and conquered, with its
high incidence and mortality, deprives countless patients of health and even life. According …
high incidence and mortality, deprives countless patients of health and even life. According …
Inflammatory microenvironment and immunotherapy in hepatocellular carcinoma
L Liu, B Liu - European Journal of Inflammation, 2023 - journals.sagepub.com
Hepatocellular carcinoma (HCC) is considered a classic inflammation-associated tumor that
usually originates from chronic hepatitis, where an intense and chronic inflammatory …
usually originates from chronic hepatitis, where an intense and chronic inflammatory …
过继性T 细胞治疗在非小细胞肺癌中的研究进展
颜次慧, 任秀宝 - 中国肿瘤临床, 2022 - cjco.cn
T 细胞是获得性抗肿瘤免疫的重要细胞亚群, 但肿瘤组织中的T 细胞数量少, 且处于免疫抑制甚至
耗竭状态, 这是导致肿瘤免疫逃逸和免疫检查点抑制剂等抗肿瘤免疫治疗效果不佳的重要原因 …
耗竭状态, 这是导致肿瘤免疫逃逸和免疫检查点抑制剂等抗肿瘤免疫治疗效果不佳的重要原因 …